Hazlett, Burt & Watson’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-218
Closed -$6K 784
2024
Q3
$6K Hold
218
﹤0.01% 588
2024
Q2
$6K Sell
218
-278
-56% -$7.97K ﹤0.01% 579
2024
Q1
$18K Hold
496
0.01% 452
2023
Q4
$18K Hold
496
0.01% 433
2023
Q3
$17K Hold
496
0.01% 434
2023
Q2
$20K Hold
496
0.01% 414
2023
Q1
$20K Hold
496
0.02% 391
2022
Q4
$15K Hold
496
0.01% 425
2022
Q3
$14K Buy
496
+326
+192% +$11.1K 0.01% 425
2022
Q2
$6K Hold
170
0.01% 499
2022
Q1
$8K Buy
+170
New +$8.99K 0.01% 493

Other funds holding XRAY

Hazlett, Burt & Watson's XRAY Position: Q4 2024 in Review

Hazlett, Burt & Watson sold out of Dentsply Sirona (XRAY) in Q4 2024, closing a stake of 218 shares — an estimated $6K sold.

Hazlett, Burt & Watson first reported a position in XRAY in Q1 2022 and held it in 11 quarters. The position peaked at $20K in Q2 2023. 359 funds tracked by Wall St. Rank hold XRAY as of Q4 2024.

  • Hazlett, Burt & Watson reported no remaining Dentsply Sirona position as of Q4 2024 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 218 Dentsply Sirona shares in Q4 2024, an estimated $6K.
  • Hazlett, Burt & Watson first reported a position in Dentsply Sirona in Q1 2022 and held it in 11 quarters.
  • Hazlett, Burt & Watson's Dentsply Sirona position peaked at $20K in Q2 2023.
  • 359 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2024.

Based on Hazlett, Burt & Watson's 13F filing for Q4 2024, filed 12 Feb 2025.